Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 25/2/2021
SIETES contiene 93212 citas

 1 a 18 de 18 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, Demets D, Evans S, Law M, McMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercok P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;388:2532-61. [Ref.ID 100988]
2. Cita con resumen
McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, Mediano O, Chen R, Drager LF, Liu Z, Chen G, Du B, McArdle N, Mukherjee S, Tripathi M, Billot L, Li Q, Lorenzi-Filho G, Barbe F, Redline S, Wang J, Arima H, Neal B, White DP, Grunstein RR, Zhong N, Anderson CS, SAVE Investigators and Coordinators. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016;375:919-31. [Ref.ID 100743]
3. Cita con resumen
Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, McMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahími K, Perkovic V, Rodgers A. Effect of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 2016;387:435-43. [Ref.ID 100094]
4.Tiene citas relacionadas Cita con resumen
Patel A, Cass A, Peiris D, Usherwood T, Brown A, Jan S, Neal B, Hillis GS, Tonkin A, Webster R, Billot L, Bompoint S, Burch C, Burke H, Hayman N, Molanus B, Reid CM, Shiel L, Togni S, Rodgers A, for the Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk. European Journal of Preventive Cardiology 2015;22:920-30. [Ref.ID 99443]
5.Tiene citas relacionadas Cita con resumen
Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA 2015;313:603-15. [Ref.ID 98794]
6.Tiene citas relacionadas Cita con resumen
Sundström J, Arima H, Jackson R, Tumbull F, Rahimi K, Chalmers J, Woodward M, Neal B, on behalf of the Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med 2015;162:184-91. [Ref.ID 98784]
7. Cita con resumen
Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE, for the AleCardio Investigators. Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus. The AleCardio randomized clinical trial . JAMA 2014;311:1515-25. [Ref.ID 97381]
8.Tiene citas relacionadas Cita con resumen
Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, Lindley R, Robinson T, Lavados P, Neal B, Hata J, Arima H, Parsons M, Li Y, Wang JC, Heritier S, Li Q, Woodward M, Simes RJ, Davis SM, Chalmers J, for the INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013;368:2355-65. [Ref.ID 95698]
9.Tiene citas relacionadas Cita con resumen
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011;377:2181-92. [Ref.ID 91346]
10.Tiene citas relacionadas Cita con resumen
Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls SJ, Gobbee DE, Cass A, Chalmers J, Perkovic V. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet 2010;375:1875-84. [Ref.ID 88606]
11.Enlace a cita originalTiene citas relacionadas
Neal B. Quantifying the importance of interleukin-6 for coronary heart disease. PLOS Medicine 2008;5:84. [Ref.ID 82756]
12.Tiene citas relacionadas
Patel A, MacMahon S, Neal B, Billot L, Chalmers J, on behalf of the ADVANCE Collaborative Group. The ADVANCE trial. Authors' reply. Lancet 2008;371:26. [Ref.ID 81858]
Monaghan H, Richens A, Colman S, Currie R, Girgis S, Jayne K, Neal B, Patel A. A randomised trial of the effects of an additional communication strategy on recruitment into a large-scale, multi-centre trial. Contemp Clin Trials 2007;28:1-5. [Ref.ID 78761]
14.Tiene citas relacionadas Cita con resumen
Fransen M, Anderson C, Douglas J, MacMahon S, Neal B, Norton R, Woodward M, Cameron ID, Crawford R, Lo SK, Tregonning G, Windolf M, for the HIPAID Collaborative Group. Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial. BMJ 2006;333:519-21. [Ref.ID 78184]
15.Tiene citas relacionadas
MacMahon S, Neal B, Rodgers A, Chalmers J. Commentary: The PROGRESS trial three years later: time for more action, less distraction. BMJ 2004;329:970-1. [Ref.ID 71708]
16.Tiene citas relacionadas Cita con resumen
17.Tiene citas relacionadas Cita con resumen
MacMahon S, Rodgers A, Neal B, Woodward M, Chalmers J, on behalf of the PROGRESS Collaborative Group. The lowering of blood pressure after stroke. Authors' reply. Lancet 2001;358:1994-5. [Ref.ID 60046]
18.Tiene citas relacionadas Cita con resumen
MacMahon S, Neal B. Differences between blood-pressure-lowering drugs. Lancet 2000;356:352-3. [Ref.ID 52097]
Seleccionar todas
 1 a 18 de 18